On 30 June Rospatent has shown an online presentation of Registry of pharmacologically active patented substances – in its prototype version. This Registry, created under commission from Russian Head of Government, shall provide all interested persons with information concerning patent protection of medicines, and shall as well help to prevent unfair practices of generics marketing before corresponding patents expire.
Main principles and routines for including the substances into the Registry, list of information subject to inclusion, its synchronization and presentation, rendering official services and submitting appeals with regards to Registry data have been already discussed by RU PTO with federal agencies and pharmaceutical manufacturers and wholesalers. It is supposed that the Registry shall be officially launched till the end of year 2021 and be cover the Russian territoryas well as the Eurasian Economic Union
https://rospatent.gov.ru/ru/news/rospatent-farmreestr-test-30062021
Russia is updating its intellectual property legislation to reflect the way modern digital technologies are…
Patentica is proud to announce that our Eurasian patent attorneys, Ekaterina Petrova and Victor Lisovenko,…
AstraZeneca has registered Baxfendi (baxdrostat) in Russia for the treatment of arterial hypertension. The medicine…
On July 10, 2026, the Eurasian Patent Organization (EAPO) acceded to the Geneva Act of…
Rospatent and Indonesia's Ministry of Law have signed a Memorandum of Understanding (MoU) to expand…
In 2026, the Eurasian industrial design system marks its fifth anniversary. Over the past five…